11/14/2024 7:01 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024 3:05 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 7:01 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 5:03 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K/A | |
09/26/2024 7:32 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 7:33 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 7:30 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/23/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 7:04 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 7:03 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2024 3:30 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 7:05 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 7:13 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 7:01 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024 7:00 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 7:13 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/29/2024 3:30 PM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024 7:00 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2024 7:02 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 7:01 AM | Enlivex Therapeutics Ltd. (Filer) Enlivex Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |